Goldman Sachs
MD icon

Goldman Sachs’s Pediatrix Medical MD Stock Holding History

Goldman Sachs’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,400
Closed -$450K – 5713
2018
Q2 		$450K Buy
+10,400
New +$498K ﹤0.01% 4570
2018
Q1 		– Sell
-74,700
Closed -$3.99M – 6193
2017
Q4 		$3.99M Buy
+74,700
New +$3.52M ﹤0.01% 3216

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Goldman Sachs's MD Position: Q2 2026 in Review

Goldman Sachs reduced its Pediatrix Medical (MD) stake by 3% in Q2 2026, selling an estimated $588K and leaving 825,636 shares worth $20.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2585.

Goldman Sachs first reported a position in MD in Q2 2013 and has held it in 53 quarters since. The position peaked at $86M in Q4 2016. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Goldman Sachs held 825,636 shares of Pediatrix Medical worth $20.9M as of Q2 2026.
  • Goldman Sachs sold 25,828 Pediatrix Medical shares in Q2 2026, an estimated $588K.
  • Pediatrix Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2585 holding.
  • Goldman Sachs first reported a position in Pediatrix Medical in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Pediatrix Medical position peaked at $86M in Q4 2016.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.